Rumi Maruyama Selected Research

Rumi Maruyama Research Topics

Disease

15	Fibrosis (Cirrhosis) 03/2012 - 05/2005
13	Myocardial Infarction 01/2018 - 04/2005
11	Infarction (Infarctions) 01/2018 - 01/2003
10	Heart Failure 01/2018 - 09/2004
5	Hypertrophy 03/2012 - 07/2005
5	Ventricular Remodeling 10/2007 - 05/2003
4	Starvation 12/2012 - 05/2009
4	Cardiomyopathies (Cardiomyopathy) 03/2012 - 01/2006
4	Cicatrix (Scar) 03/2009 - 01/2006
3	Inflammation (Inflammations) 03/2012 - 09/2006
3	Cardiomegaly (Heart Hypertrophy) 07/2011 - 02/2003
3	Ischemia 04/2011 - 04/2005
3	Necrosis 06/2009 - 10/2008
3	Atrophy 02/2008 - 01/2006
2	Cardiotoxicity 12/2012 - 02/2010
2	Hypoxia (Hypoxemia) 06/2011 - 08/2010
2	Peripheral Arterial Disease 04/2011 - 06/2009
2	Anemia 11/2010 - 08/2010
2	Diabetic Nephropathies (Diabetic Nephropathy) 11/2008 - 01/2006
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2006 - 02/2003
1	Left Ventricular Dysfunction 03/2012
1	Albuminuria 11/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2007
1	Coronary Occlusion 11/2006

Drug/Important Bio-Agent (IBA)

7	Adenosine Triphosphate (ATP)IBA 12/2012 - 01/2003
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2011 - 01/2006
6	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2012 - 01/2006
6	Erythropoietin FDA Link 03/2012 - 01/2006
4	Cathepsin DIBA 12/2012 - 07/2006
4	Green Fluorescent ProteinsIBA 12/2012 - 05/2009
4	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2012 - 05/2009
4	Proteins (Proteins, Gene)FDA Link 03/2012 - 09/2002
3	Amino Acids FDA Link 06/2011 - 05/2009
3	Fas Ligand Protein (Fas Ligand)IBA 02/2010 - 09/2004
3	UbiquitinIBA 10/2009 - 07/2006
3	Autophagy-Related ProteinsIBA 10/2009 - 07/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2009 - 10/2008
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2008 - 05/2003
2	asialoerythropoietinIBA 03/2012 - 11/2010
2	bafilomycin A1IBA 06/2011 - 05/2009
2	GelatinIBA 04/2011 - 06/2009
2	HydrogelsIBA 04/2011 - 06/2009
2	Erythropoietin Receptors (Erythropoietin Receptor)IBA 11/2010 - 01/2006
2	CytokinesIBA 03/2009 - 09/2006
2	Sirolimus (Rapamycin)FDA Link 01/2009 - 10/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 11/2008 - 05/2005
2	DesminIBA 05/2007 - 01/2006
2	Myosin Heavy Chains (Myosin Heavy Chain)IBA 05/2007 - 01/2006
2	Type 1 Angiotensin ReceptorIBA 05/2007 - 03/2007
2	Troponin IIBA 05/2007 - 01/2006
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2005 - 01/2003
1	ResveratrolIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Autophagy-Related Protein-1 HomologIBA 12/2012
1	AMP-Activated Protein KinasesIBA 12/2012
1	Phosphotransferases (Kinase)IBA 12/2012
1	Sarcoglycans (beta Sarcoglycan)IBA 03/2012
1	Atrial Natriuretic Factor (ANF)IBA 07/2011
1	DNA (Deoxyribonucleic Acid)IBA 11/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2010
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2010
1	DecorinIBA 10/2009
1	bafilomycin AIBA 10/2009
1	Oxidants (Oxidizing Agents)IBA 06/2009
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 06/2009
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2009
1	Acid PhosphataseIBA 05/2009
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2009
1	Transforming Growth Factor-beta Type II ReceptorIBA 11/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2008
1	parthenolideIBA 08/2008
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2007
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 10/2007
1	CalcineurinIBA 10/2007
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2007
1	Amlodipine (Norvasc)FDA LinkGeneric 10/2007
1	Calcineurin InhibitorsIBA 10/2007
1	Verapamil (Calan)FDA LinkGeneric 10/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2007
1	Nifedipine (Adalat)FDA LinkGeneric 10/2007
1	AngiotensinsIBA 05/2007
1	Protein Kinases (Protein Kinase)IBA 05/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2007
1	ReninIBA 05/2007
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 05/2007
1	olmesartanIBA 05/2007
1	ChloridesIBA 11/2006
1	2,3-dihydroxybenzoic acidIBA 11/2006
1	EdaravoneIBA 11/2006
1	Free Radical ScavengersIBA 11/2006
1	Hydroxyl RadicalIBA 11/2006
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 11/2006
1	Therapeutic UsesIBA 07/2005

Therapy/Procedure

5	Therapeutics 01/2018 - 05/2005
4	Ligation 06/2011 - 02/2003
2	Intraperitoneal Injections 12/2012 - 01/2006
2	Microspheres (Microsphere) 04/2011 - 06/2009
2	Nephrectomy 11/2010 - 03/2007
1	Caloric Restriction 01/2018
1	Intramuscular Injections 02/2010